
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MFF CRISPR/Cas9 KO Plasmid (h) | sc-402756 | 20 µg | $397.00 |
Human MFF (mitochondrial fission factor) is an outer mitochondrial membrane adaptor that recruits the dynamin-related GTPase DRP1 to promote mitochondrial and peroxisomal division, shaping organelle morphology and distribution. Through control of fission–fusion balance, MFF influences mitochondrial network architecture, mitophagy, apoptosis sensitivity, and cellular bioenergetics, with downstream effects on oxidative phosphorylation, ROS handling, and stress signaling. Perturbation of MFF-dependent fission is linked to altered mitochondrial dynamics and has been associated with neurodevelopmental and neurodegenerative phenotypes, as well as broader metabolic dysfunction where organelle quality control is disrupted. As a core node in mitochondrial dynamics pathways, MFF is frequently studied in contexts of organelle homeostasis, innate immune signaling, and cell fate decisions.
MFF CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the MFF gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the MFF together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the MFF open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MFF protein expression.
This CRISPR knockout system enables efficient generation of MFF-deficient cell models for investigation of MFF signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.